glp 1 drugs and muscle loss matters: the effects of medically induced weight on skeletal muscle Glucagon-like peptide-1 receptor agonists and

Here, we test whether GLP-1RAs alter alcohols peripheral pharmacokinetics as a potential mechanism of action for their alcohol intake suppressive effects

In an investigative report in partnership with KFF Health News, NBC News Anne Thompson reports on the growing cases of overdoses involving GLP-1 weight loss drugs.

Shocking Truth: Compounded GLP-1s on Groupon pose serious health risks

Anyway, we are currently facing a novel and very appealing therapeutic option.

In clinical practice, drug selection should therefore prioritize factors such as tolerability, safety profile, adherence, cost, and patient preference rather than expecting major differences in cardiovascular efficacy.